Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Arrhythmias

Free Subscription Articles published in J Cardiol Retrieve available abstracts of 45 articles: HTML format

Single Articles

September 2025
1. MATSUNAGA-LEE Y, Egami Y, Ohsuga M, Abe M, et al
   Novel tailored very-high-power short-duration radiofrequency ablation around the esophagus guided by left atrial voltage.
   J Cardiol. 2025;86:249-255.
   PubMed     Abstract available
   
   
   August 2025
2. HASEGAWA K, Stevenson WG
   Antithrombotic Management in Catheter Ablation for ventricular arrhythmias -Mini review.
   J Cardiol. 2025 Aug 21:S0914-5087(25)00210-2. doi: 10.1016/j.jjcc.2025.
   PubMed     Abstract available
   
   
   
3. WATTANACHAYAKUL P, Yanpiset P, Kulthamrongsri N, Prasitsumrit V, et al
   Prognostic values of atrial high-rate episodes on mortality risks in CIED patients.
   J Cardiol. 2025;86:194-201.
   PubMed     Abstract available
   
   
   July 2025
4. SATO H, Takahashi N
   Temporal and geographical trends in anticoagulant therapy and catheter ablation for atrial fibrillation in Japan, 2014-2022.
   J Cardiol. 2025 Jul 23:S0914-5087(25)00192-3. doi: 10.1016/j.jjcc.2025.
   PubMed     Abstract available
   
   
   
5. MAO F, Sun Y, Du X, Fu G, et al
   Surface steel ball calibration - A novel method for facilitating fluoroscopic measurement during implantation of WATCHMAN.
   J Cardiol. 2025;86:32-37.
   PubMed     Abstract available
   
   
   June 2025
6. AIZAWA N, Tanno K, Furuya T, Ishinaga T, et al
   Very high-power short-duration ablation for superior vena cava isolation in patients with recurrent atrial fibrillation.
   J Cardiol. 2025 Jun 28:S0914-5087(25)00168-6. doi: 10.1016/j.jjcc.2025.
   PubMed     Abstract available
   
   
   May 2025
7. YAMAGISHI Y, Watabe T, Nakahara D, Taniguchi K, et al
   Characteristics of anxiety about returning to work after implantable cardioverter defibrillator implantation in Japan.
   J Cardiol. 2025 May 30:S0914-5087(25)00143-1. doi: 10.1016/j.jjcc.2025.
   PubMed     Abstract available
   
   
   
8. AIJAZ A, Magsi IA, Zeeshan I
   Critique on "mitral regurgitation in atrial fibrillation: is a simple repair enough to tackle a complex problem?".
   J Cardiol. 2025 May 27:S0914-5087(25)00135-2. doi: 10.1016/j.jjcc.2025.
   PubMed    
   
   
   April 2025
9. NAKANO T, Oka T, Okayama K, Tanaka N, et al
   Association between oral anticoagulants continuation on thromboembolism and bleeding events in patients with CHADS(2) score 0-2 points after catheter ablation for persistent atrial fibrillation.
   J Cardiol. 2025 Apr 24:S0914-5087(25)00103-0. doi: 10.1016/j.jjcc.2025.
   PubMed     Abstract available
   
   
   
10. NISHINARITA R, Oikawa J, Arao K, Sugisaki K, et al
    Prognosis of low-flow low-gradient aortic valve stenosis with atrial fibrillation.
    J Cardiol. 2025 Apr 2:S0914-5087(25)00097-8. doi: 10.1016/j.jjcc.2025.
    PubMed     Abstract available
    
    
    
11. SHINOHARA M, Saji M, Koike H, Ohara H, et al
    Current evidence and indications for left atrial appendage closure.
    J Cardiol. 2025;85:268-274.
    PubMed     Abstract available
    
    
    March 2025
12. OKAJIMA T, Ishikawa S, Uemura Y, Ozaki Y, et al
    Efficacy of sodium-glucose cotransporter 2 inhibitors on preventing atrial arrhythmia recurrences after atrial fibrillation ablation in patients with heart failure.
    J Cardiol. 2025 Mar 19:S0914-5087(25)00088-7. doi: 10.1016/j.jjcc.2025.
    PubMed     Abstract available
    
    
    
13. AWAD AK, Elbahloul MA, Gamal A, Attia AN, et al
    Efficacy of surgical ablation and left atrial appendage occlusion in patients with AF undergoing coronary artery bypass grafting: A network meta-analysis.
    J Cardiol. 2025;85:177-185.
    PubMed     Abstract available
    
    
    
14. KAWAJI T, Hayashi T, Nishimura T, Nagashima K, et al
    3D mapping quest: How far can we see with recent advances in 3D mapping?
    J Cardiol. 2025;85:204-212.
    PubMed     Abstract available
    
    
    February 2025
15. SONG ZQ, Lu XY, Xu YP, Lin H, et al
    Author's reply to "how to indicate left atrial posterior wall isolation adjunctive to conventional pulmonary vein isolation in patients with atrial fibrillation".
    J Cardiol. 2025 Feb 14:S0914-5087(25)00063-2. doi: 10.1016/j.jjcc.2025.
    PubMed    
    
    
    
16. TALPUR H, Mustafa G
    Mitral regurgitation in atrial fibrillation: Is a simple repair enough to tackle a complex problem?
    J Cardiol. 2025 Feb 13:S0914-5087(25)00059-0. doi: 10.1016/j.jjcc.2025.
    PubMed    
    
    
    
17. ALBAKAA NK, Sato K, Kawamatsu N, Yamamoto M, et al
    Imaging characteristics of patients with cardiac sarcoidosis who presented with ventricular arrhythmias.
    J Cardiol. 2025 Feb 12:S0914-5087(25)00035-8. doi: 10.1016/j.jjcc.2025.
    PubMed     Abstract available
    
    
    
18. KATAOKA N, Imamura T
    How to indicate left atrial posterior wall isolation adjunctive to conventional pulmonary vein isolation in patients with atrial fibrillation.
    J Cardiol. 2025 Feb 6:S0914-5087(25)00020-6. doi: 10.1016/j.jjcc.2025.
    PubMed    
    
    
    
19. DIMITRIADIS K, Pyrpyris N, Iliakis P, Kanatas P, et al
    Optimal management of high bleeding risk patients undergoing percutaneous coronary interventions: Where do we stand?
    J Cardiol. 2025;85:79-87.
    PubMed     Abstract available
    
    
    
20. WAKAMATSU Y, Nagashima K, Watanabe R, Hirata S, et al
    Beyond the lens: Unveiling the invisible atrioventricular node in the era of high-density mapping.
    J Cardiol. 2025;85:56-62.
    PubMed     Abstract available
    
    
    January 2025
21. BASILE P, Guaricci AI
    Author's reply to the Letter to the Editor "How to demonstrate the causal relationship between sodium-glucose cotransporter 2 receptor and prevention of ventricular arrhythmia in heart failure cohorts".
    J Cardiol. 2025 Jan 31:S0914-5087(25)00012-7. doi: 10.1016/j.jjcc.2025.
    PubMed    
    
    
    
22. KATAOKA N, Imamura T
    How to demonstrate the causal relationship between sodium-glucose cotransporter 2 receptor and prevention of ventricular arrhythmia in heart failure cohorts.
    J Cardiol. 2025 Jan 20:S0914-5087(25)00006-1. doi: 10.1016/j.jjcc.2025.
    PubMed    
    
    
    
23. BAZOUKIS G, Hui JMH, Saplaouras A, Efthymiou P, et al
    The impact of new-onset atrial fibrillation in the setting of acute coronary syndrome.
    J Cardiol. 2025 Jan 7:S0914-5087(24)00233-8. doi: 10.1016/j.jjcc.2024.
    PubMed     Abstract available
    
    
    
24. PASCOE MA, Kolodziej A, Birks EJ, Vaidya G, et al
    Using electronic medical records to identify patients at risk for underlying cardiac amyloidosis.
    J Cardiol. 2025;85:43-44.
    PubMed     Abstract available
    
    
    December 2024
25. KHAN S, Javed R, Amin S
    Mitral regurgitation in atrial fibrillation: Is a simple repair enough to tackle a complex problem?
    J Cardiol. 2024 Dec 12:S0914-5087(24)00226-0. doi: 10.1016/j.jjcc.2024.
    PubMed    
    
    
    
26. KAMADA H, Iriki Y, Yoshimoto I, Ninomiya Y, et al
    Incidence and predictors of persistent iatrogenic atrial septal defect following catheter ablation.
    J Cardiol. 2024;84:372-378.
    PubMed     Abstract available
    
    
    October 2024
27. KOMURO J, Kaneko H, Suzuki Y, Okada A, et al
    Unawareness of being prescribed medications for diabetes and incident cardiovascular disease.
    J Cardiol. 2024;84:294-299.
    PubMed     Abstract available
    
    
    September 2024
28. SONG ZQ, Lu XY, Xu YP, Lin H, et al
    The role of left atrium posterior wall isolation in patients undergoing catheter ablation for atrial fibrillation.
    J Cardiol. 2024 Sep 26:S0914-5087(24)00180-1. doi: 10.1016/j.jjcc.2024.
    PubMed     Abstract available
    
    
    
29. BASILE P, Monitillo F, Santoro D, Falco G, et al
    Impact on ventricular arrhythmic burden of SGLT2 inhibitors in patients with chronic heart failure evaluated with cardiac implantable electronic device monitoring.
    J Cardiol. 2024 Sep 13:S0914-5087(24)00177-1. doi: 10.1016/j.jjcc.2024.
    PubMed     Abstract available
    
    
    
30. MATSUOKA Y, Sotomi Y, Hikoso S, Sunaga A, et al
    Extensive ablation for elderly patients with persistent atrial fibrillation: insights from the EARNEST-PVI prospective randomized trial.
    J Cardiol. 2024 Sep 7:S0914-5087(24)00173-4. doi: 10.1016/j.jjcc.2024.
    PubMed     Abstract available
    
    
    August 2024
31. YOSHII T, Amano M, Moriuchi K, Nakagawa S, et al
    Usefulness of exercise stress echocardiography for predicting cardiovascular events and atrial fibrillation in hypertrophic cardiomyopathy.
    J Cardiol. 2024 Aug 28:S0914-5087(24)00170-9. doi: 10.1016/j.jjcc.2024.
    PubMed     Abstract available
    
    
    
32. ROMERO CE, Pereira NM, Morales KP, Kerges Bueno BV, et al
    Echocardiographic factors associated with thromboembolic events in patients with cardiac amyloidosis without atrial fibrillation.
    J Cardiol. 2024 Aug 9:S0914-5087(24)00147-3. doi: 10.1016/j.jjcc.2024.
    PubMed     Abstract available
    
    
    June 2024
33. OKISHIGE K, Tachibana S, Shigeta T, Yamauchi Y, et al
    Novel method to avoid serious injurious effects on the atrioventricular nodal (AVN) conduction during catheter ablation of the AVN slow pathway utilizing cryofreezing energy.
    J Cardiol. 2024;83:371-376.
    PubMed     Abstract available
    
    
    May 2024
34. YAMAGUCHI T
    Atrial structural remodeling and atrial fibrillation substrate: A histopathological perspective.
    J Cardiol. 2024 May 27:S0914-5087(24)00096-0. doi: 10.1016/j.jjcc.2024.
    PubMed     Abstract available
    
    
    
35. KURODA S, Kawamura I, Sahashi Y, Kuno T, et al
    The significance of non-sustained ventricular tachycardia on life-threatening ventricular arrhythmia events in patients with non-ischemic cardiomyopathy in the contemporary era: A systematic review and meta-analysis.
    J Cardiol. 2024 May 14:S0914-5087(24)00086-8. doi: 10.1016/j.jjcc.2024.
    PubMed     Abstract available
    
    
    
36. VLACHAKIS PK, Tsiachris D, Doundoulakis I, Tsioufis P, et al
    Therapeutic inertia in rhythm control strategies in hospitalized patients with fibrillation: Insights from Hellenic Cardiorenal Morbidity Snapshot (HECMOS) study.
    J Cardiol. 2024;83:313-317.
    PubMed     Abstract available
    
    
    March 2024
37. BAZOUKIS G, Saplaouras A, Efthymiou P, Yiannikourides A, et al
    Atrial fibrillation in the setting of cardiac amyloidosis - A review of the literature.
    J Cardiol. 2024 Mar 31:S0914-5087(24)00053-4. doi: 10.1016/j.jjcc.2024.
    PubMed     Abstract available
    
    
    
38. IMBURGIO S, Johal A, Akhlaq H, Klei L, et al
    Fatal ventricular arrhythmias in myocarditis: A review of current indications for defibrillator devices.
    J Cardiol. 2024 Mar 27:S0914-5087(24)00054-6. doi: 10.1016/j.jjcc.2024.
    PubMed     Abstract available
    
    
    February 2024
39. SUGAWARA M, Kondo Y, Ryuzaki S, Yoshino Y, et al
    Long-term prognosis and prognostic factors after primary prophylactic implantable cardioverter-defibrillator therapy.
    J Cardiol. 2024 Feb 19:S0914-5087(24)00024-8. doi: 10.1016/j.jjcc.2024.
    PubMed     Abstract available
    
    
    December 2023
40. TOMSIC A, Meucci MC, de Jong AR, Braun J, et al
    Mitral regurgitation in atrial fibrillation: Is a simple repair enough to tackle a complex problem?
    J Cardiol. 2023 Dec 14:S0914-5087(23)00295-2. doi: 10.1016/j.jjcc.2023.
    PubMed     Abstract available
    
    
    November 2023
41. YAMAMOTO T, Nambu Y, Bo R, Morichi S, et al
    Electrocardiographic R wave amplitude in V6 lead as a predictive marker of cardiac dysfunction in Duchenne muscular dystrophy.
    J Cardiol. 2023;82:363-370.
    PubMed     Abstract available
    
    
    
42. NARUMI T, Naruse Y, Miyajima K, Kaneko Y, et al
    Actual conditions of atrial septal lead implantation and the factors related to successful implantation.
    J Cardiol. 2023;82:371-377.
    PubMed     Abstract available
    
    
    October 2023
43. WENG CJ, Li CH, Lin YJ, Chang SL, et al
    Skin Sympathetic Nerve Activity in Different Ablation Settings for Atrial Fibrillation.
    J Cardiol. 2023 Oct 12:S0914-5087(23)00247-2. doi: 10.1016/j.jjcc.2023.
    PubMed     Abstract available
    
    
    
44. HARA H, Kubo S, Nakajima Y, Matsumoto T, et al
    Initial results of transcatheter modification of left atrial appendage by obliteration with device in patients with nonvalvular atrial fibrillation: Real-world data from the TERMINATOR registry.
    J Cardiol. 2023 Oct 5:S0914-5087(23)00240-X. doi: 10.1016/j.jjcc.2023.
    PubMed     Abstract available
    
    
    September 2023
45. NAGASE T, Kikuchi T, Unno T, Arai R, et al
    Impedance-guided modified CLOSE protocol ablation can reduce ablation index necessary for pulmonary vein isolation in patients with atrial fibrillation.
    J Cardiol. 2023 Sep 7:S0914-5087(23)00224-1. doi: 10.1016/j.jjcc.2023.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Arrhythmias is free of charge.